ENGOT-EN1/NSGO-FANDANGO
Trial Description:
ENGOT-EN1/FANDANGO: A Randomized Phase II Trial of First-line Combination Chemotherapy With Nintedanib / Placebo for Patients With Advanced or Recurrent Endometrial Cancer
Lead Cooperative Group:
Trial Number:
Disease Site:
Recurrent Endometrial
Trial Status:
Completed
Contact person:
mraza